IPS Genomix and ‘Personalized Medicine in Oncology’

A symposium organized by IPS Genomix on the concept of Personalized Medicine in Oncology in September 2013. (The Daily Star/HO)

Under the auspices of the Lebanese Association for Oncology, IPS Genomix has organized a symposium on the concept of Personalized Medicine in Oncology, hosted by Professor Fadlo Khuri, head of hematology – oncology section at Emory University and vice president of Winship Cancer Institute-USA.

First, the IPS (Integrated Pharma Solutions) Group CEO, Ahmed Yacout, talked about the interest given by the company to Personalized Medicine in Oncology.

The president of the Lebanese Society of Medical Oncology and chairman of the hematology-oncology department at Hotel Dieu de France University hospital, Professor George Chahine, has inaugurated the symposium.

A session has been dedicated to discussing and answering the questions of the participants, and was shared by the head of the hematology-oncology division at AUBMC, Professor Ali Shamseddine.

The participants followed with great interest the presentation of Professor Khuri that comprised the development stages of Personalized Medicine in Oncology, since “the existing scientific revolution in the fields of medicine and genetic researches has engendered a positive development in the quality of health care provided to cancer patients.

The idea of personalized medicine is not new. However, nowadays, with the technique of detailed genetic tests, a more precise and efficient personalized treatment is possible to eradicate the cancerous tumor, with less side effects on the patient.”

He added: “We are at a time when the cost of treating cancer is high, whether it is a chemical treatment or a targeted therapy. Now, and due to genetic tests, we are capable of knowing more details about the tumor, about each patient and the specificity of his case. This means that we are capable of obtaining better results, at a lower cost.”





Your feedback is important to us!

We invite all our readers to share with us their views and comments about this article.

Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.

Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (

comments powered by Disqus



Interested in knowing more about this story?

Click here